Olubanke Dzahini
Overview
Explore the profile of Olubanke Dzahini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oloyede E, Bachmann C, Dzahini O, Lopez Alcaraz J, Singh S, Vallianatu K, et al.
Br J Psychiatry
. 2024 Aug;
225(5):484-491.
PMID: 39149780
Background: Clozapine is the most effective antipsychotic for treatment-resistant psychosis. However, clozapine is underutilised in part because of potential agranulocytosis. Accumulating evidence indicates that below-threshold haematological readings in isolation are...
2.
Connolly A, Wallman P, Dzahini O, Howes O, Taylor D
Psychopharmacology (Berl)
. 2024 Jan;
241(2):225-241.
PMID: 38238580
Rationale: Dopamine antagonists induce dopamine receptor supersensitivity. This may manifest in late-appearing movement disorders (tardive dyskinesia (TD). VMAT-2 inhibitors reduce dopaminergic transmission but have limited activity at postsynaptic receptors and...
3.
Oloyede E, Dima A, Taylor D, Cheung H, Dzahini O, Shergill S, et al.
Acta Psychiatr Scand
. 2023 Oct;
148(6):538-552.
PMID: 37899506
Background: Up to 30% of patients with a diagnosis of treatment-resistant psychosis remain symptomatic despite an optimal trial with the gold standard treatment, clozapine. Emerging evidence suggests the clinical utility...
4.
Oloyede E, Dzahini O, Abolou Z, Gee S, Whiskey E, Malhotra D, et al.
Br J Psychiatry
. 2023 Apr;
223(2):382-388.
PMID: 37092691
Background: To minimise infection during COVID-19, the clozapine haematological monitoring interval was extended from 4-weekly to 12-weekly intervals in South London and Maudsley NHS Foundation Trust. Aims: To investigate the...
5.
Oloyede E, Blackman G, Whiskey E, Bachmann C, Dzahini O, Shergill S, et al.
Epidemiol Psychiatr Sci
. 2022 Nov;
31:e83.
PMID: 36426600
Aims: Clozapine is licensed for treatment-resistant psychosis and remains underutilised. This may berelated to the stringent haematological monitoring requirements that are mandatory in most countries. We aimed to compare guidelines...
6.
Redaelli S, Porffy L, Oloyede E, Dzahini O, Lewis G, Lobo M, et al.
Ther Adv Psychopharmacol
. 2022 Jul;
12:20451253221110014.
PMID: 35833056
Background: The evidence for safe and effective interventions to treat the negative and cognitive symptoms of schizophrenia is lacking. Objectives: Vortioxetine is a novel antidepressant that has been used as...
7.
Oloyede E, Whiskey E, Casetta C, Dzahini O, Dunnett D, Gandhi S, et al.
Lancet Psychiatry
. 2022 Jun;
9(8):636-644.
PMID: 35772414
Background: Clozapine is uniquely effective in treatment-resistant psychosis. In the UK, patients must discontinue clozapine indefinitely if they are placed on the Central Non-Rechallenge Database (CNRD) after their haematological parameters...
8.
Livermore C, White H, Bailey L, Osborne I, Oloyede E, Dzahini O, et al.
BMC Psychiatry
. 2022 Apr;
22(1):277.
PMID: 35443629
Objective: The objective of the study is to explore the long-term effectiveness and tolerability of metoclopramide in the treatment of CIH. Method: This study is a retrospective, observational cohort study...
9.
Taylor D, Vallianatou K, Whiskey E, Dzahini O, MacCabe J
Schizophrenia (Heidelb)
. 2022 Mar;
8(1):21.
PMID: 35288577
The wider use of clozapine is limited by the risk of agranulocytosis and the associated requirement for monitoring of neutrophil counts. We searched local electronic patient records for cases of...
10.
Mace S, Dzahini O, Cornelius V, Langerman H, Oloyede E, Taylor D
J Psychopharmacol
. 2022 Jan;
36(2):232-237.
PMID: 34991402
Background: To examine the risk of infection in patients prescribed clozapine compared with patients prescribed paliperidone palmitate long-acting injection (PPLAI). Method: A retrospective, 1-year, cohort study conducted on events occurring...